SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skywatcher who wrote (380)2/21/1997 1:22:00 PM
From: Roudy   of 1762
 
Hi Chris, I was informed this morning that IDEC was intiated a strong buy from Credit Suisse First Boston by Shekhar Basu. He was formally with Punk Zegal and is now the Biotech Analyst for First Boston. He also had a strong buy on IDEC while at Punk Zegal. This analyst rating along with the earnings report is putting alot of action on IDEC today. Hopefully we will break out of this trading pattern on the high volume. Have a good day, Don.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News